Monopar Therapeutics Inc.
$69.27
-2.53 (-3.52%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -32.6%
- 3 Months
- -34.6%
- YTD
- +6.1%
- 1 Year
- -23.4%
- 3 Year annualized
- +208.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 63.1%
- Largest decline max drawdown, since Oct 2021
- -94.5%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.11
Own MNPR?
See how MNPR contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.